ClinicalTrials.gg
Drug

Rebastinib clinical trials

Also written DCC-2036.

studies test it
3
open now
0
in phase 3
0
first study started
2009

How each study uses rebastinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rebastinib
3

Development codes

DCC-2036
3

Studies by the year they started

3 studies that test it; most in 2009 (1)

Studies that test rebastinib, by start year
YearStudies
20091
20181
20191

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 0

Deciphera Pharmaceuticals, LLC (3)

Often tested with

Tested in the same studies.

Carboplatin (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses rebastinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

Given beside what is tested · 1 — rebastinib is usual care or a partner of the new treatment

Codes

What other systems call rebastinib · ClinicalTrials.gg INT000961

  • MeSH (NLM) C000627803rebastinibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 75017Q6I97REBASTINIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q27088522rebastinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152162RebastinibOne source FDA
  • DrugBank DB13005One source Wikidata

Also registered as rebastinib tosylate (UNII 042A5NJE6B).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.